Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Apr. 03, 2022
Mar. 31, 2021
Jan. 02, 2022
Dec. 31, 2020
Cash flows from operating activities:        
Net income (loss) $ 42,707 $ (16,165) $ (125,874) $ (39,650)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation 314 141 995 579
Amortization of right-of-use assets 134 0 520 0
Stock-based compensation expense 5,238 1,555 10,711 666
Changes in fair value of convertible preferred stock warrants and common stock warrants (67,800) 4,781 56,141 13,789
Issuance of convertible preferred stock warrants (non-cash)     0 1,476
Change in fair value of convertible promissory notes     0 2,422
Loss (gain) on early debt extinguishment     60 (1,628)
Interest expense (non-cash)     0 107
Changes in operating assets and liabilities:        
Prepaid expenses and other assets (51) 1,039 (2,497) (577)
Deferred contract costs 8 (816) (967) (2,482)
Accounts payable (959) 1,172 1,523 1,826
Accrued expenses and compensation 555 1,260 5,193 2,617
Deferred revenue     2,370 185
Deferred rent     0 681
Other liabilities 165 (1,577) 519 (61)
Net cash used in operating activities (19,689) (8,610) (51,306) (20,050)
Cash flows from investing activities:        
Purchase of property and equipment (10,451) (7,141) (43,584) (26,953)
Net cash used in investing activities (10,451) (7,141) (43,584) (26,953)
Cash flows from financing activities:        
Proceeds from Business Combination and PIPE financing     405,155 0
Payments of transaction costs related to Business Combination and PIPE financing 0 (332) (31,410) 0
Proceeds from issuance of convertible preferred stock, net     0 63,932
Proceeds from exercise of common stock warrants, net 52,828 0 77,170 0
Proceeds from secured promissory notes, converted promissory notes and paycheck protection program loan     15,000 0
Proceeds from paycheck protection program loan     0 1,628
Repayment of secured promissory note     (15,000) 0
Payment of debt issuance costs     (90) 0
Proceeds from exercise of convertible preferred stock warrants 0 102 102 0
Proceeds from the exercise of stock options 200 159 190 360
Repurchase of unvested restricted common stock (3) (5) (27) 0
Net cash provided by (used in) financing activities 53,025 (76) 451,090 65,920
Change in cash, cash equivalents, and restricted cash 22,885 (15,827) 356,200 18,917
Cash and cash equivalents and restricted cash, beginning of period 385,418 29,218 29,218 10,301
Cash and cash equivalents, and restricted cash, end of period 408,303 13,391 385,418 29,218
Supplemental cash flow data (Non-cash):        
Net liabilities assumed from Business Combination     73,400 0
Purchase of property and equipment included in liabilities 1,510 1,690    
Accrued purchase of transaction costs     5,488 3,181
Conversion of promissory notes to convertible preferred stock     0 8,073
Settlement of accrued interest expense through conversion of promissory notes to convertible preferred stock     0 130
Issuance of convertible preferred stock warrants     0 1,476
Gain on extinguishment of the paycheck protection program loan     $ 0 $ 1,628
Accrued transaction costs $ 0 $ 3,579